Skip to main content
OpenTrials

Clinical trial condition

Classical Hodgkin Lymphoma Refractory

Explore clinical trials studying Classical Hodgkin Lymphoma Refractory. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Classical Hodgkin Lymphoma Refractory trial results

Recruiting

Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma

NCT06822855

Conditions
Classical Hodgkin Lymphoma, Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory
Locations
  • ASST Grande Ospedale Metropolitano Niguarda Milan, MI, Italy
  • Azienda USL IRCCS di Reggio Emilia Reggio Emilia, RE, Italy
  • A.O.S.G. Moscati Avellino, Italy
  • Spedali Civili Brescia Brescia, Italy
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)

NCT06504394

Conditions
Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory, Parkinson Disease 4, Autosomal Dominant Lewy Body, +2 more
Locations
  • University of Iowa-Holden Comprehensive Cancer Center ( Site 0115) Iowa City, Iowa, United States
  • University of Iowa - Waukee ( Site 0111) Waukee, Iowa, United States
  • Comprehensive Cancer Centers of Nevada ( Site 0114) Las Vegas, Nevada, United States
  • Clinical Research Alliance ( Site 0101) Westbury, New York, United States
View all 29 locations
View Trial Details

Related conditions